Atlas Trials

Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome

Clinical trial NCT00673751 · UNKNOWN

Trial details

NCT number
NCT00673751
Sponsor
Glostrup University Hospital, Copenhagen
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Short Bowel Syndrome
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.